CNS regulation of plasma cholesterol

References

• Lund-Katz S, Phillips MC. High density lipoprotein structure-function and role in reverse cholesterol transport. Subcell Biochem. 2010;51:183–227.
   PubMedGoogle Scholar
• Berthoud HR, Morrison C. The brain, appetite, and obesity. Annu Rev Psychol. 2008;59:55–92.
   PubMed Web of Science ®Google Scholar
• Grill HJ. Distributed neural control of energy balance: contributions from hindbrain and hypothalamus. Obesity (Silver Spring). 2006;14 Suppl 5:216S–21S.
   Google Scholar
• Sandoval DA, Obici S, Seeley RJ. Targeting the CNS to treat type 2 diabetes. Nat Rev Drug Discov. 2009;8:386–98.
   PubMed Web of Science ®Google Scholar
• Lam TK, Gutierrez-Juarez R, Pocai A, Bhanot S, Tso P, Schwartz GJ, . Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins. Nat Med. 2007;13:171–80.
   PubMed Web of Science ®Google Scholar
• Perez-Tilve D, Hofmann SM, Basford J, Nogueiras R, Pfluger PT, Patterson JT, . Melanocortin signaling in the CNS directly regulates circulating cholesterol. Nat Neurosci. 2010;13:877–82.
   PubMedGoogle Scholar
• Stafford JM, Yu F, Printz R, Hasty AH, Swift LL, Niswender KD. Central nervous system neuropeptide Y signaling modulates VLDL triglyceride secretion. Diabetes. 2008;57:1482–90.
   PubMed Web of Science ®Google Scholar
• van den Hoek AM, Voshol PJ, Karnekamp BN, Buijs RM, Romijn JA, Havekes LM, . Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin. Diabetes. 2004;53:2529–34.
   Google Scholar
• Cohen BE, Marmar C, Ren L, Bertenthal D, Seal KH. Association of cardiovascular risk factors with mental health diagnoses in Iraq and Afghanistan war veterans using VA health care. JAMA. 2009;302:489–92.
   PubMed Web of Science ®Google Scholar
• Frideman M, Rosenman RH, Carroll V. Changes in the serum cholesterol and blood clotting time in men subjected to cyclic variation of occupational stress. Circulation. 1958;17:852–61.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Griffin AC. Effects of periodic mental stress on serum cholesterol levels. Circulation. 1959;19:496–8.
   PubMed Web of Science ®Google Scholar
• Taggart P, Carruthers M. Endogenous hyperlipidaemia induced by emotional stress of racing driving. Lancet. 1971;297:363–6.
   Google Scholar
• Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354:1435–9.
   PubMed Web of Science ®Google Scholar
• Gangwisch JE, Malaspina D, Babiss LA, Opler MG, Posner K, Shen S, . Short sleep duration as a risk factor for hypercholesterolemia: analyses of the National Longitudinal Study of Adolescent Health. Sleep. 2010;33:956–61.
   PubMed Web of Science ®Google Scholar
• Kerkhofs M, Boudjeltia KZ, Stenuit P, Brohee D, Cauchie P, Vanhaeverbeek M. Sleep restriction increases blood neutrophils, total cholesterol and low density lipoprotein cholesterol in postmenopausal women: A preliminary study. Maturitas. 2007;56:212–5.
   PubMed Web of Science ®Google Scholar
• Lalovic A, Merkens L, Russell L, Arsenault-Lapierre G, Nowaczyk MJ, Porter FD, . Cholesterol metabolism and suicidality in Smith-Lemli-Opitz syndrome carriers. Am J Psychiatry. 2004;161:2123–6.
   PubMed Web of Science ®Google Scholar
• Lalovic A, Levy E, Luheshi G, Canetti L, Grenier E, Sequeira A, . Cholesterol content in brains of suicide completers. Int J Neuropsychopharmacol. 2007;10:159–66.
   PubMed Web of Science ®Google Scholar
• Morgan RE, Palinkas LA, Barrett-Connor EL, Wingard DL. Plasma cholesterol and depressive symptoms in older men. Lancet. 1993;341:75–9.
   PubMed Web of Science ®Google Scholar
• Alvarez JC, Cremniter D, Lesieur P, Gregoire A, Gilton A, Macquin-Mavier I, . Low blood cholesterol and low platelet serotonin levels in violent suicide attempters. Biol Psychiatry. 1999;45:1066–9.
   PubMed Web of Science ®Google Scholar
• Garland MR, Hallahan B, McNamara M, Carney PA, Grimes H, Hibbeln JR, . Lipids and essential fatty acids in patients presenting with self-harm. Br J Psychiatry. 2007;190:112–7.
   PubMed Web of Science ®Google Scholar
• Boston PF, Dursun SM, Reveley MA. Cholesterol and mental disorder. Br J Psychiatry. 1996;169:682–9.
   PubMed Web of Science ®Google Scholar
• Alvarez JC, Cremniter D, Gluck N, Quintin P, Leboyer M, Berlin I, . Low serum cholesterol in violent but not in non-violent suicide attempters. Psychiatry Res. 2000;95:103–8.
   PubMed Web of Science ®Google Scholar
• Dietschy JM. Central nervous system: cholesterol turnover, brain development and neurodegeneration. Biol Chem. 2009;390:287–93.
   PubMed Web of Science ®Google Scholar
• Edgar PF, Hooper AJ, Poa NR, Burnett JR. Violent behavior associated with hypocholesterolemia due to a novel APOB gene mutation. Mol Psychiatry. 2007;12:258–63; 221.
   PubMed Web of Science ®Google Scholar
• Stewart RA, Sharples KJ, North FM, Menkes DB, Baker J, Simes J. Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators. Arch Intern Med. 2000;160:3144–52.
   PubMedGoogle Scholar
• Wirshing DA, Boyd JA, Meng LR, Ballon JS, Marder SR, Wirshing WC. The effects of novel antipsychotics on glucose and lipid levels. J Clin Psychiatry. 2002;63:856–65.
   PubMed Web of Science ®Google Scholar
• Bjorkhem I, Leoni V, Meaney S. Genetic connections between neurological disorders and cholesterol metabolism. J Lipid Res. 2010;51:2489–503.
   PubMed Web of Science ®Google Scholar
• Nixon RA. Niemann-Pick type C disease and Alzheimer's disease: the APP-endosome connection fattens up. Am J Pathol. 2004;164:757–61.
   PubMed Web of Science ®Google Scholar
• Love S, Bridges LR, Case CP. Neurofibrillary tangles in Niemann-Pick disease type C. Brain. 1995;118 (Pt 1):119–29.
   Google Scholar
• Puglielli L, Tanzi RE, Kovacs DM. Alzheimer's disease: the cholesterol connection. Nat Neurosci. 2003;6:345–51.
   PubMed Web of Science ®Google Scholar
• Bu G. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci. 2009;10:333–44.
   PubMed Web of Science ®Google Scholar
• Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel DP, Tocco M, . Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med. 2003;163:1053–7.
   PubMed Web of Science ®Google Scholar
• Solomon A, Kivipelto M, Wolozin B, Zhou J, Whitmer RA. Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord. 2009;28:75–80.
   PubMed Web of Science ®Google Scholar
• Mielke MM, Zandi PP, Sjogren M, Gustafson D, Ostling S, Steen B, . High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology. 2005;64:1689–95.
   PubMed Web of Science ®Google Scholar
• Solomon A, Kareholt I, Ngandu T, Winblad B, Nissinen A, Tuomilehto J, . Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology. 2007;68:751–6.
   PubMed Web of Science ®Google Scholar
• Stewart R, White LR, Xue QL, Launer LJ. Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study. Archives of neurology. 2007;64:103–7.
   PubMed Web of Science ®Google Scholar
• Mielke MM, Zandi PP, Shao H, Waern M, Ostling S, Guo X, . The 32-year relationship between cholesterol and dementia from midlife to late life. Neurology. 2010;75:1888–95.
   PubMed Web of Science ®Google Scholar
• Bjorkhem I, Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol. 2004;24:806–15.
   PubMed Web of Science ®Google Scholar
• Lütjohann D, Breuer O, Ahlborg G, Nennesmo I, Sidén A, Diczfalusy U, . Cholesterol homeostasis in human brain: Evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci U S A. 1996;93:9799–804.
   PubMed Web of Science ®Google Scholar
• Heverin M, Meaney S, Lütjohann D, Diczfalusy U, Wahren J, Björkhem I. Crossing the barrier: Net flux of 27-hydroxycholesterol into the human brain. J Lipid Res. 2005;46:1047–52. PMID: 15741649.
   PubMed Web of Science ®Google Scholar
• Mateos L, Akterin S, Gil-Bea F-J, Spulber S, Rahman A, Björkhem I, . Activity-regulated cytoskeleton-associated protein in rodent brain is down-regulated by high fat diet in vivo and by 27-hydroxycholesterol in vitro. Brain Pathol. 2009;19:69–80.
   PubMed Web of Science ®Google Scholar
• Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H. Dietary fats, cholesterol and iron as risk factors for Parkinson's disease. Parkinsonism Relat Disord. 2009;15:47–52.
   PubMed Web of Science ®Google Scholar
• de Lau LM, Koudstaal PJ, Hofman A, Breteler MM. Serum cholesterol levels and the risk of Parkinson's disease. Am J Epidemiol. 2006;164:998–1002.
   PubMed Web of Science ®Google Scholar
• Hu G, Antikainen R, Jousilahti P, Kivipelto M, Tuomilehto J. Total cholesterol and the risk of Parkinson disease. Neurology. 2008;70:1972–9.
   PubMed Web of Science ®Google Scholar
• Simon KC, Chen H, Schwarzschild M, Ascherio A. Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology. 2007;69:1688–95.
   PubMed Web of Science ®Google Scholar
• Hoebel BG, Teitelbaum P. Hypothalamic control of feeding and self-stimulation. Science. 1962;135:375–7.
   PubMed Web of Science ®Google Scholar
• Halpern CH, Wolf JA, Bale TL, Stunkard AJ, Danish SF, Grossman M, . Deep brain stimulation in the treatment of obesity. J Neurosurg. 2008;109:625–34.
   PubMed Web of Science ®Google Scholar
• Gunn CG, Friedman M, Byers SO. Effect of chronic hypothalamic stimulation upon cholesterol-induced atherosclerosis in the rabbit. J Clin Invest. 1960;39:1963–72.
   PubMedGoogle Scholar
• Somoza C. Serum cholesterol levels and aortic medial calcification in rabbits with lesions in the brain. Am J Pathol. 1965;47:271–85.
   Google Scholar
• Gutstein WH, Schneck DJ, Appleton H. Mechanism of plasma lipid increases following brain stimulation. Metabolism. 1969;18:300–10.
   Google Scholar
• Bernardis L, Schnatz J. Localization in the ventromedial hypothalamic nuclei of an area affecting plasma triglyceride and cholesterol levels. J Neurovisc Relat. 1971;32:90–103.
   Google Scholar
• Frohman LA, Bernardis LL, Schnatz JD, Burek L. Plasma insulin and triglyceride levels after hypothalamic lesions in weanling rats. Am J Physiol. 1969;216:1496–501.
   Google Scholar
• Byers SO, Friedman M. Neurogenic hypercholesterolemia. 3. Cholesterol synthesis, absorption, and clearance. Am J Physiol. 1973;225:1322–6.
   Google Scholar
• Inoue S, Satoh S, Tanaka K, Takamura Y, Murase T. Determinants of fasting hypertriglyceridemia in ventromedial hypothalamic obesity in rats. Am J Physiol. 1993;265(Pt 2):R786–91.
   Google Scholar
• Friedman M, Byers SO, Elek S. Neurogenic hypercholesterolemia. II. Relationship to endocrine function. Am J Physiol. 1972;223:473–9.
   Google Scholar
• de Luca C, Kowalski TJ, Zhang Y, Elmquist JK, Lee C, Kilimann MW, . Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. J Clin Invest. 2005;115:3484–93.
   PubMed Web of Science ®Google Scholar
• Huynh FK, Levi J, Denroche HC, Gray SL, Voshol PJ, Neumann UH, . Disruption of hepatic leptin signaling protects mice from age- and diet-related glucose intolerance. Diabetes. 2010;59:3032–40.
   Google Scholar
• Bartels ED, Lauritsen M, Nielsen LB. Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice. Diabetes. 2002;51:1233–9.
   Google Scholar
• Wiegman CH, Bandsma RH, Ouwens M, van der Sluijs FH, Havinga R, Boer T, . Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin. Diabetes. 2003;52:1081–9.
   PubMedGoogle Scholar
• Redgrave TG. Catabolism of chylomicron triacylglycerol and cholesteryl ester in genetically obese rats. J Lipid Res. 1977;18:604–12.
   PubMed Web of Science ®Google Scholar
• Narvekar P, Berriel Diaz M, Krones-Herzig A, Hardeland U, Strzoda D, Stohr S, . Liver-specific loss of lipolysis-stimulated lipoprotein receptor triggers systemic hyperlipidemia in mice. Diabetes. 2009;58:1040–9.
   Google Scholar
• VanPatten S, Ranginani N, Shefer S, Nguyen LB, Rossetti L, Cohen DE. Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance. Am J Physiol Gastrointest Liver Physiol. 2001;281: G393–404.
   Google Scholar
• Hyogo H, Roy S, Cohen DE. Restoration of gallstone susceptibility by leptin in C57BL/6J ob/ob mice. J Lipid Res. 2003;44:1232–40.
   Google Scholar
• Vanpatten S, Karkanias GB, Rossetti L, Cohen DE. Intracerebroventricular leptin regulates hepatic cholesterol metabolism. Biochem J. 2004;379(Pt 2):229–33.
   Google Scholar
• Biddinger SB, Hernandez-Ono A, Rask-Madsen C, Haas JT, Alemán JO, Suzuki R, . Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab. 2008;7:125–34.
   PubMed Web of Science ®Google Scholar
• Silver DL, Jiang XC, Tall AR. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover. J Biol Chem. 1999;274:4140–6.
   PubMed Web of Science ®Google Scholar
• Silver DL, Wang N, Tall AR. Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake. J Clin Invest. 2000;105:151–9.
   Google Scholar
• Lundasen T, Liao W, Angelin B, Rudling M. Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7alpha-hydroxylase (Cyp7a1) in leptin-deficient (ob/ob) mice. J Biol Chem. 2003;278:43224–8.
   PubMed Web of Science ®Google Scholar
• Gruen ML, Plummer MR, Zhang W, Posey KA, Linton MF, Fazio S, . Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I. J Lipid Res. 2005;46:2007–14.
   Google Scholar
• Myers MG Jr, Munzberg H, Leinninger GM, Leshan RL. The geometry of leptin action in the brain: more complicated than a simple ARC. Cell Metab. 2009;9:117–23.
   PubMed Web of Science ®Google Scholar
• Bjorbaek C. Central leptin receptor action and resistance in obesity. J Investig Med. 2009;57:789–94.
   PubMed Web of Science ®Google Scholar
• van den Top M, Lee K, Whyment AD, Blanks AM, Spanswick D. Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus. Nat Neurosci. 2004;7:493–4.
   PubMed Web of Science ®Google Scholar
• Balthasar N, Coppari R, McMinn J, Liu SM, Lee CE, Tang V, . Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron. 2004;42:983–91.
   PubMed Web of Science ®Google Scholar
• Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, . Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 2001;411:480–4.
   PubMed Web of Science ®Google Scholar
• Huo L, Gamber K, Greeley S, Silva J, Huntoon N, Leng XH, . Leptin-dependent control of glucose balance and locomotor activity by POMC neurons. Cell Metab. 2009;9:537–47.
   PubMed Web of Science ®Google Scholar
• Sutton GM, Trevaskis JL, Hulver MW, McMillan RP, Markward NJ, Babin MJ, . Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors. Endocrinology. 2006;147:2183–96.
   PubMed Web of Science ®Google Scholar
• Adage T, Scheurink AJ, de Boer SF, de Vries K, Konsman JP, Kuipers F, . Hypothalamic, metabolic, and behavioral responses to pharmacological inhibition of CNS melanocortin signaling in rats. J Neurosci. 2001;21:3639–45.
   Google Scholar
• Fan W, Dinulescu DM, Butler AA, Zhou J, Marks DL, Cone RD. The central melanocortin system can directly regulate serum insulin levels. Endocrinology. 2000; 141:3072–9.
   PubMed Web of Science ®Google Scholar
• Albarado DC, McClaine J, Stephens JM, Mynatt RL, Ye J, Bannon AW, . Impaired coordination of nutrient intake and substrate oxidation in melanocortin-4 receptor knockout mice. Endocrinology. 2004;145:243–52.
   Google Scholar
• Tao YX. The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr Rev. 2010;31: 506–43.
   PubMed Web of Science ®Google Scholar
• Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, . Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466:707–13.
   PubMed Web of Science ®Google Scholar
• Chen D, Liao J, Li N, Zhou C, Liu Q, Wang G, . A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice. Proc Natl Acad Sci U S A. 2007;104:943–8.
   Google Scholar
• Sandoval DA, Bagnol D, Woods SC, D'Alessio DA, Seeley RJ. Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes. 2008; 57:2046–54.
   Google Scholar
• Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407:908–13.
   PubMed Web of Science ®Google Scholar
• O'Donnell L, Owens D, McGee C, Devery R, Hession P, Collins P, . Effects of catecholamines on serum lipoproteins of normally fed and cholesterol-fed rabbits. Metabolism. 1988;37:910–5.
   Google Scholar
• O'Meara NM, Devery RA, Owens D, Collins PB, Johnson AH, Tomkin GH. Alterations in cellular cholesterol metabolism following administration of 6-hydroxydopamine to rabbits. Br J Pharmacol. 1992;105:495–9.
   Google Scholar
• Byers SO, Friedman M, Elek SR, Diamant J, Neuman R. Neurogenic hypercholesterolemia: influence of autonomic drugs. Atherosclerosis. 1976;24:189–98.
   Google Scholar
• Tavares FL, Seelaender MC. Hepatic denervation impairs the assembly and secretion of VLDL-TAG. Cell Biochem Funct. 2008;26:557–65.
   Google Scholar